Fundamental Analysis
69 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +38.5% | +279.4% | 3 / 3 | +44.1% | -2.88 pp | +0.62 pp | +3.1% | 1.26 | 21.23 | 1.911 | +44,1% | 35,0 | +118,3% | 21.23 | 56.05 | −62,1% |
| Pts | 8 | 12 | 12 | 12 | 4 | 8 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 10.600 (close price on 2026-10-19)EPS (TTM): 499,2
Financial charts
1.Revenue & growth
VND bn1.911Q2/26
1.Revenue & growth
VND bn1.911Q2/26
2.Profit & growth
VND bn30,0Q2/26
3.Profit mix (Penman)
VND bn223Q2/26
4.Margins & cost structure
%13.0%Q2/26
5.Returns & cash cycle
% · days4.2%Q2/26
6.Earnings quality & cash
VND bn507Q2/26
7.Asset structure
VND bn11.105Q2/26
8.Funding & debt health
VND bn · times11.105Q2/26
9.Revenue backlog
VND bn1.455Q2/26
10.Valuation
times · %21,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %191Q2/26
Adjusted EPS growth, latest quarter
38.5%
Average adjusted EPS growth, 3 quarters
38.5%
averaged over 1 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26